A treatment option for Medication-resistant fibromyalgia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: adult patients with a modified ACR 2010 diagnosis of fibromyalgia and major depressive disorder
Exclusion criteria
Exclusion criteria: Patients were excluded if they had a lifetime psychiatric history of psychotic disorders, bipolar I or II disorder, substance abuse or dependence, personality disorders (based on DSM-IV criteria) or a lifetime medical history of major systemic illness, neurological disorders (e.g. stroke, post-brain surgery, epilepsy, traumatic brain injury), or cardiac pacemakers, brain implants or neurostimulators; or if they were pregnant.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the changing of VAS-pain (week-2 vs. baseline) in response to the 2-week prefrontalrTMS | — |
Secondary
| Measure | Time frame |
|---|---|
| FDG-PET; CANTAB for working memory, go/no-goand MSCEIT; serum IL-2, IL-6, TNF-alpha, insulin, CRP; Young mania Rating scale; Clinical Global Index; Hamilton Depression Rating Scales-17 item; Life stress scale; Pittsburgh Sleep Quality Index;12-Item Short Form Health Survey; short-form McGill Pain Questionnaire; Patient Health Questionnaire | — |
Countries
Asia(except Japan)
Contacts
Taipei Veterans General Hospital, Taiwan Psychiatry